News items Launch of DRIVE-AMS

18 November 2022

On the 1st of November 2022, Radboud University Medical Centre (Radboudumc) and University of Antwerp joined forces to launch DRIVE-AMS, a new project funded under the EU4Health Programme. This project aims to intensify antimicrobial stewardship (AMS) programmes across the European Union by improving prudent antimicrobial use (AMU) and strengthening AMU surveillance, which are both key priorities of the EU One Health Action Plan on AMR.

In 2018, Radboudumc developed the Dutch Antimicrobial Stewardship, Masterclass & Expert consultancy programme, providing a guidance for professionals and policy makers through the process of developing and implementing a successful Antimicrobial Stewardship Program in healthcare facilities. In 2014, the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS), was developed by the Laboratory of Medical Microbiology of the University of Antwerp, to provide a standardized, feasible and freely available web-based surveillance tool for measuring the quality of antimicrobial prescribing practice in hospitals worldwide.
These two programmes are now working together in the DRIVE-AMS project. It combines three key elements: knowledge transfer, measurement, and expert consultation.

DRIVE-AMS will be implemented in four European countries (Greece, Lithuania, Portugal and Romania) where national AMS experts will be trained as trainer. DRIVE-AMS will enhance the impact of sustainable AMS implementation, through:

  • Understanding principles of Antimicrobial Stewardship through an online pre-course
  • Identifying gaps in antimicrobial prescribing by a pre-course Global-PPS
  • Providing a 4-day Masterclass for Antimicrobial Stewardship teams on development and implementation of AMS interventions. Prepare a plan of action for "My Project”
  • Providing 6-9 month expert support for the execution of  “My Project” in the participants’ own hospital practice
  • Measuring impact by a post-course Global-PPS

DRIVE-AMS will run for 3 years and will officially kick off with an online meeting on 9 December 2022, with the participation of all implementing partners: the Institute of Hygiene from Lithuania, the Aristotle University of Thessaloniki from Greece, the Iuliu Hațieganu University of Medicine and Pharmacy from Romania, and the University Hospital Centre of São João  from Portugal.

Related news items

Field research on malaria vaccine offers unexpected surprise

23 May 2022

Field research on the effectiveness of a malaria vaccine, came up with unexpected results for an international group of researchers including Benjamin Mordmüller of Radboudumc. The vaccine evokes a broader response against malaria proteins than there are in the vaccine.

read more

With concerted effort, tuberculosis could be eradicated in 30 years time March 24th was World Tuberculosis Day

24 March 2022 Since 2020, the number of deaths from tuberculosis increased for the first time in a decade, caused by the COVID pandemic: fewer people had access to the right care on time. Some catching up is needed. read more

HIV drug approved for young children Research on optimal dosing published in The Lancet HIV

16 March 2022 For young children with HIV, there is now an effective and safe drug available that inhibits the infection. read more

What does the shingles vaccine teach us about other vaccines? Investigating the role of trained immunity

27 January 2022 The vaccine for shingles, a condition that causes itching, pain, and blisters, is 90% effective, even in elderly. This is remarkable, since most vaccines offer less protection in elderly. Radboudumc is investigating why this vaccine works so well and how it might help us to develop better vaccines. read more